INFINITT Healthcare Co., Ltd. (KOSDAQ:071200)

INFINITT Healthcare Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	103,728	101,570	88,476	88,286	78,170	70,069
Other Revenue	0	-	-0	-	-0	-
Revenue	103,728	101,570	88,476	88,286	78,170	70,069
Revenue Growth (YoY)	7.78%	14.80%	0.21%	12.94%	11.56%	-5.65%
Cost of Revenue	39,530	37,599	36,620	34,754	32,371	26,891
Gross Profit	64,198	63,971	51,855	53,532	45,799	43,179
Selling, General & Admin	38,996	37,969	34,086	33,565	27,952	26,493
Research & Development	8,000	9,208	8,635	8,039	7,378	5,757
Amortization of Goodwill & Intangibles	127.97	134.47	133.61	138.67	108.5	106.35
Other Operating Expenses	388.62	277.76	254.94	268.2	272.09	234.81
Operating Expenses	53,563	50,281	45,226	45,675	38,691	36,008
Operating Income	10,635	13,691	6,629	7,857	7,108	7,171
Interest Expense	-117.8	-131.75	-132.38	-121.79	-118.18	-139.36
Interest & Investment Income	2,804	2,982	1,779	1,164	743.52	419.58
Earnings From Equity Investments	-8.44	-38.63	100.77	22.47	65.12	-163.71
Currency Exchange Gain (Loss)	1,547	3,627	675.15	-698.68	1,836	-1,187
Other Non Operating Income (Expenses)	374.97	85.79	-12.43	320.9	2,311	235.35
EBT Excluding Unusual Items	15,235	20,215	9,039	8,544	11,946	6,336
Gain (Loss) on Sale of Investments	27,767	34,039	15,210	-11,648	14,071	492.58
Gain (Loss) on Sale of Assets	9.59	-30.97	-5.79	0.46	-1.11	-3.72
Asset Writedown	-0.08	-0.08	-	-	-	-122.76
Other Unusual Items	-	-	20.38	8.84	8.98	1,611
Pretax Income	43,012	54,223	24,264	-3,095	26,025	8,312
Income Tax Expense	4,773	7,516	3,972	-3,256	3,386	1,645
Earnings From Continuing Operations	38,238	46,707	20,292	160.93	22,639	6,667
Earnings From Discontinued Operations	-1,083	-2,066	-818.3	-	-	-
Net Income to Company	37,156	44,642	19,474	160.93	22,639	6,667
Minority Interest in Earnings	-307.69	-718.19	-335.66	-29.36	17.65	15.49
Net Income	36,848	43,923	19,139	131.57	22,656	6,683
Net Income to Common	36,848	43,923	19,139	131.57	22,656	6,683
Net Income Growth	23.40%	129.50%	14446.72%	-99.42%	239.02%	-7.79%
Shares Outstanding (Basic)	25	24	24	24	24	24
Shares Outstanding (Diluted)	25	24	24	24	24	24
Shares Change (YoY)	1.16%	-	-	-0.19%	0.19%	-
EPS (Basic)	1502.90	1801.88	785.12	5.40	929.44	274.16
EPS (Diluted)	1502.90	1801.88	785.12	5.00	928.00	274.00
EPS Growth	21.99%	129.50%	15602.46%	-99.46%	238.69%	-7.74%
Free Cash Flow	8,093	11,664	9,563	8,281	15,424	14,955
Free Cash Flow Per Share	330.09	478.50	392.29	339.72	631.52	613.50
Gross Margin	61.89%	62.98%	58.61%	60.63%	58.59%	61.62%
Operating Margin	10.25%	13.48%	7.49%	8.90%	9.09%	10.23%
Profit Margin	35.52%	43.24%	21.63%	0.15%	28.98%	9.54%
Free Cash Flow Margin	7.80%	11.48%	10.81%	9.38%	19.73%	21.34%
EBITDA	13,026	16,284	9,127	10,418	9,468	9,300
EBITDA Margin	12.56%	16.03%	10.32%	11.80%	12.11%	13.27%
D&A For EBITDA	2,390	2,594	2,498	2,561	2,360	2,130
EBIT	10,635	13,691	6,629	7,857	7,108	7,171
EBIT Margin	10.25%	13.48%	7.49%	8.90%	9.09%	10.23%
Effective Tax Rate	11.10%	13.86%	16.37%	-	13.01%	19.79%
Advertising Expenses	-	2,099	1,999	1,695	804.23	820.39

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.